These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6336623)

  • 1. Delineation of optimal conditions for producing mouse-human heterohybridomas from human peripheral blood B cells of immunized subjects.
    Butler JL; Lane HC; Fauci AS
    J Immunol; 1983 Jan; 130(1):165-8. PubMed ID: 6336623
    [No Abstract]   [Full Text] [Related]  

  • 2. Production of stable heterohybridomas producing human monoclonal antibodies.
    Cooper MD; Kirkpatrick R
    Methods Mol Biol; 1995; 45():29-39. PubMed ID: 7550689
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple subsets of anti-tetanus toxoid antibody-producing cells in human peripheral blood differ by size, expression of membrane receptors, and mitogen reactivity.
    Thiele CJ; Morrow CD; Stevens RH
    J Immunol; 1981 Mar; 126(3):1146-53. PubMed ID: 6970218
    [No Abstract]   [Full Text] [Related]  

  • 4. A human monoclonal antibody specific for tetanus toxoid.
    Olsson L; Mazauric T; Vincent-Falquet JC; Armand J
    Dev Biol Stand; 1984; 57():87-91. PubMed ID: 6526153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of human-human hybridoma from anti-Her-2 peptide-producing B cells in immunized NOG mouse.
    Kametani Y; Shiina M; Katano I; Ito R; Ando K; Toyama K; Tsukamoto H; Matsumura T; Saito Y; Ishikawa D; Taki T; Ito M; Imai K; Tokuda Y; Kato S; Tamaoki N; Habu S
    Exp Hematol; 2006 Sep; 34(9):1240-8. PubMed ID: 16939817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody potential of human peripheral blood lymphocytes differentially expressing surface membrane IgM.
    Thiele CJ; Stevens RH
    J Immunol; 1980 Apr; 124(4):1898-904. PubMed ID: 6767777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimisation of human anti-tetanus toxoid antibody responses and location of human cells in SCID mice transplanted with human peripheral blood leucocytes.
    Jackson DJ; Kumpel BM
    Hum Antibodies; 1997; 8(4):181-8. PubMed ID: 9395920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High efficiency creation of human monoclonal antibody-producing hybridomas.
    Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
    J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of T cell subsets during tetanus infection treated with high doses of specific immunoglobulins.
    De Paoli P; Battistin S; Reitano M; Castiglia C; Santini GF
    Boll Ist Sieroter Milan; 1984 Jul; 63(3):196-200. PubMed ID: 6239637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective role of membrane IgG in the antigen-induced inhibition of human in vitro antibody synthesis.
    Stevens RH; Benveniste E; Pineda E
    J Immunol; 1982 Jan; 128(1):398-401. PubMed ID: 6798112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immune response in active-passive immunization against tetanus].
    Bozović M
    Med Pregl; 1986; 39(7-8):327-9. PubMed ID: 3547064
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of the failure of resting B cells to present tetanus toxoid antigen to T cells.
    Brozek C; Umetsu D; Schneeberger E; Geha RS
    J Immunol; 1984 Mar; 132(3):1144-50. PubMed ID: 6607279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro stimulation of human peripheral blood B cells from normal individuals by activated T cells increases the efficiency of hybridoma generation.
    Ferraro AS; Newkirk MM
    Hum Antibodies Hybridomas; 1993 Apr; 4(2):80-5. PubMed ID: 8100151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the optimal human cell lines for development of human hybridomas.
    Abrams PG; Knost JA; Clarke G; Wilburn S; Oldham RK; Foon KA
    J Immunol; 1983 Sep; 131(3):1201-4. PubMed ID: 6350451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of human-human hybridomas secreting antibody to sheep erythrocytes after in vitro immunization.
    Strike LE; Devens BH; Lundak RL
    J Immunol; 1984 Apr; 132(4):1798-803. PubMed ID: 6699402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human anti-tetanus antibody response in vitro: autologous and allogeneic T cells provide help by different routes.
    Brenner MK; Munro AJ
    Clin Exp Immunol; 1981 Oct; 46(1):171-7. PubMed ID: 6978212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoclonal antibodies produced by human-human hybridomas].
    Chida J
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences in the production of human monoclonal antibodies to tetanus toxoid.
    Boyd JE; Hastings I; Farzad Z; James K; McClelland DB
    Dev Biol Stand; 1984; 57():93-8. PubMed ID: 6526155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human hybridomas secreting antibody to tetanus toxoid.
    Larrick JW; Truitt KE; Raubitschek AA; Senyk G; Wang JC
    Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6376-80. PubMed ID: 6578513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.